STERIS plc

NYSE STE

STERIS plc Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2024: USD 680.11 M

STERIS plc Free Cash Flow is USD 680.11 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 27.02% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • STERIS plc Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 535.44 M, a 34.29% change year over year.
  • STERIS plc Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 398.72 M, a -0.43% change year over year.
  • STERIS plc Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 400.45 M, a 0.23% change year over year.
  • STERIS plc Free Cash Flow for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 399.54 M, a 14.99% change year over year.
Key data
Date Free Cash Flow Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities
Market news
Loading...
NYSE: STE

STERIS plc

CEO Mr. Daniel A. Carestio
IPO Date June 1, 1992
Location Ireland
Headquarters 70 Sir John Rogerson's Quay
Employees 18,000
Sector Health Care
Industries
Description

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Similar companies

PODD

Insulet Corporation

USD 267.04

-0.35%

BRKR

Bruker Corporation

USD 61.26

-2.69%

CNMD

CONMED Corporation

USD 67.79

-2.46%

LIVN

LivaNova PLC

USD 47.63

0.66%

SYK

Stryker Corporation

USD 362.80

0.50%

MASI

Masimo Corporation

USD 166.09

0.31%

ITGR

Integer Holdings Corporation

USD 138.83

2.72%

PEN

Penumbra, Inc.

USD 252.89

2.41%

BSX

Boston Scientific Corporation

USD 95.65

1.10%

ZIMV

ZimVie Inc.

USD 13.47

-1.25%

IRTC

iRhythm Technologies, Inc.

USD 99.01

4.67%

ANIK

Anika Therapeutics, Inc.

USD 15.58

-2.14%

GKOS

Glaukos Corporation

USD 147.95

-2.58%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

StockViz Staff

January 15, 2025

Any question? Send us an email